Dr. Komaki is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
1515 Holcombe Blvd UT MDACC
Unit 97
Houston, TX 77030Phone+1 713-563-2300
Education & Training
- Medical College of Wisconsin Affiliated HospitalsResidency, Radiation Oncology, 1974 - 1978
- Ascension Columbia St. Mary's Milwaukee HospitalInternship, Transitional Year, 1972 - 1973
- OtherClass of 1969
Certifications & Licensure
- TX State Medical License 1992 - 2026
- WI State Medical License 1976 - 2017
- NY State Medical License 1985 - 2007
- American Board of Radiology Radiation Oncology
- American Board of Radiology Therapeutic Radiology
Awards, Honors, & Recognition
- Gold Medalist of ARS in 2022
- Gloria Lupton Tennison Endowed Chair for the Lung Cancer Research at MDACC
Clinical Trials
- Combined Modality Treatment for Resectable Non-Small Cell Superior Sulcus Tumors Start of enrollment: 1993 Oct 01
- High-Dose or Standard-Dose Radiation Therapy and Chemotherapy With or Without Cetuximab in Treating Patients With Newly Diagnosed Stage III Non-Small Cell Lung Cancer That Cannot Be Removed by Surgery Start of enrollment: 2007 Nov 01
- CPT-11/Cisplatin and Celecoxib With Radiation Therapy for Patients With Unresectable Non-Small Cell Lung Cancer (NSCLC) Start of enrollment: 2003 Sep 01
- Join now to see all
Publications & Presentations
PubMed
- Prognostic Factors in Limited-Stage Small Cell Lung Cancer: A Secondary Analysis of CALGB 30610-RTOG 0538.Michael K Farris, Michael D Mix, Xiaofei Wang, Brandy Jaszewski, Nathan Foster
JAMA Network Open. 2024-10-01 - Long-Term Prospective Outcomes of Intensity Modulated Radiotherapy for Locally Advanced Lung Cancer: A Secondary Analysis of a Randomized Clinical Trial.Stephen G Chun, Chen Hu, Ritsuko U Komaki, Robert D Timmerman, Steven E Schild
JAMA Oncology. 2024-08-01 - The Inherited KRAS-variant as a Biomarker of Cetuximab Response in NSCLC.Joanne B Weidhaas, Chen Hu, Ritsuko Komaki, Gregory A Masters, George R Blumenschein
Cancer Research Communications. 2023-10-11
Grant Support
- RTOG, NRGNCI1988–2018
Committees
- Member, Institutional Board Review at MDACC 1998 - 2018
- Co-Chair, Lung Cancer Committee of RTOG/NRG 1998 - 2018
Research History
- PI of RTOGPI of RTOG from MDACC1990 - 2018
- Section Chief of Thoracic Radiation Oncology at MDACC1988 - 2018
Professional Memberships
- Member
Other Languages
- Japanese
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: